Search results for "derived"

showing 10 items of 452 documents

Modulation of platelet activation and initial cytokine release by alloplastic bone substitute materials.

2010

Objectives: Platelet-derived cytokines play a crucial role in tissue regeneration. In regenerative dental medicine, bone substitute materials (BSM) are widely used. However, initial interactions of BSM and platelets are still unknown. The aim of this study was to evaluate the potential of platelet activation and subsequent initial cytokine release by different commercial alloplastic BSM. Material and methods: Eight commercial BSM of different origins and chemical compositions (tricalcium phosphate, hydroxyapatite, bioactive glass: SiO2 and mixtures) were incubated with a platelet concentrate (platelet-rich plasma, PRP) of three healthy volunteers at room temperature for 15 min. Platelet cou…

Blood PlateletsCalcium PhosphatesVascular Endothelial Growth Factor APlatelet Aggregationmedicine.medical_treatmentPharmacologyCell Degranulationlaw.inventionlawmedicineHumansPlateletPlatelet activationPlatelet-Derived Growth FactorbiologyChemistryPlatelet CountPlatelet-Rich PlasmaGrowth factorDegranulationFlow CytometryPlatelet ActivationSilicon DioxideP-SelectinCytokineDurapatiteBioactive glassPlatelet-rich plasmaImmunologyBone Substitutesbiology.proteinOral SurgeryPlatelet-derived growth factor receptorClinical oral implants research
researchProduct

Analysis and comparison of autologous platelet-rich plasma preparation systems used in the treatment of enthesopathies: A preliminary study

2021

Background Autologous platelet-rich plasma (PRP) injection is an alternative but widely accepted method for the treatment of degenerative changes in tendon attachments known as enthesopathies. The PRP is considered a safe source for high concentrations of the growth factors involved in the healing process. Despite initial promising outcomes, many recent studies report conflicting results for this treatment. This may be due to differences in the concentrations of platelets and growth factors in PRPs obtained using different methods. Objectives The aim of this study was to compare PRP preparation systems in terms of morphotic components and selected growth factors to find the most appropriate…

Blood PlateletsMaleVascular Endothelial Growth Factor APlatelet-derived growth factormedicine.medical_treatmentPopulationMedicine (miscellaneous)EnthesopathyGeneral Biochemistry Genetics and Molecular Biologyplatelet-derived growth factorTransforming Growth Factor beta1AndrologyLeukocyte Countchemistry.chemical_compoundEpidermal growth factorgrowth factorsInternal MedicinemedicineHumansPharmacology (medical)PlateleteducationGenetics (clinical)Whole bloodeducation.field_of_studyEpidermal Growth FactorPlatelet-Rich Plasmabusiness.industryGrowth factorVascular endothelial growth factorchemistryPlatelet-rich plasmaReviews and References (medical)businessAdvances in Clinical and Experimental Medicine
researchProduct

The Harvest Smart PRePTMsystem versus the Friadent-Schütze platelet-rich plasma kit

2003

An important reason to improve methods for isolating platelet-rich plasma (PRP) is the potential use of autogenous platelet growth factors. In addition to the Curasan PRP kit (Curasan, Kleinostheim, Germany) and the platelet concentrated collection system (PCCSTM) system, two new methods for the preparation of PRP by the surgeon are now available. This study compared the suitability of these new methods for the preparation of PRP. Whole blood was drawn from 54 healthy donors (33 men and 21 women) aged 23-79 years (38.0 +/- 17.7 years). PRP was prepared from each donor's blood using both the Smart PRePTM system (Harvest Technologies Corporation, Munich, Germany) and the Friadent-Schutze meth…

Blood transfusionbiologyChemistryGrowth factormedicine.medical_treatmentBuffy coatCollection systemAndrologyPlatelet-rich plasmaImmunologybiology.proteinmedicinePlateletOral SurgeryPlatelet-derived growth factor receptorWhole bloodClinical Oral Implants Research
researchProduct

Influence of a collagen membrane and recombinant platelet-derived growth factor on vertical bone augmentation in implant-fixed deproteinized bovine b…

2012

Combinations of bone substitute block materials with membrane techniques as well as with growth factors are possible options to enhance the prognosis of vertical bone augmentation. Therefore, the aim of the pilot study was to compare the influence of a collagen membrane and a signal protein (rhPDGF-BB) on vertical bone augmentation with a stable fixed block material (deproteinized bovine bone [DBB]).In 12 rabbits, a DBB-block was implant-fixed on the tibia in a split-leg-design. Included were: DBB only (control), DBB + collagen membrane (test), DBB + rhPDGF-BB (test) and DBB + rhPDGF-BB + collagen membrane (test). 24 samples were examined after 3 (n = 12) and 6 weeks (n = 12). Calculated pa…

Bone RegenerationBecaplerminDentistryPilot ProjectsBone augmentationRecombinant Platelet-Derived Growth FactorAnimalsProspective StudiesTibiaDental ImplantsChemistrybusiness.industryCollagen membraneAlveolar Ridge AugmentationProto-Oncogene Proteins c-sisBovine boneMembraneBone SubstitutesCattleCollagenRabbitsImplantOral SurgerybusinessBiomedical engineeringFixed BlockClinical Oral Implants Research
researchProduct

Human Spheroids from Adipose-Derived Stem Cells Induce Calvarial Bone Production in a Xenogeneic Rabbit Model

2020

ABSTRACT: Calvarial defects can result from several causes. Tissue engineering hold the potential to restore native form and protective function. We have recently shown that stemness and differentiation ability of spheroids from adipose-derived stem cells (S-ASCs) promotes osteoblasts growth within Integra in a small vertebral lesion. In our study, we aimed to test osteogenic potential of S-ASCs in aiding regeneration of a calvarial defect. Groups containing Integra showed increased bone regeneration at the calvarial defect-Integra interface compared with the control group. In particular, S-ASC-derived osteoblasts group showed a superior calvarial remodeling than undifferentiated S-ASCs gro…

Bone RegenerationCellular differentiationAdipose tissueBone healing030230 surgerySettore MED/08 - Anatomia Patologica03 medical and health sciences0302 clinical medicineTissue engineeringOsteogenesisAdipocytesAnimalsHumansMedicinespheroids.Bone regenerationCells Culturedadipose-derived stem cellbusiness.industryOssificationStem CellsRegeneration (biology)SkullCell DifferentiationCell biologyAdipose Tissue030220 oncology & carcinogenesisSurgeryRabbitsmedicine.symptomStem cellbusiness
researchProduct

Microglial involvement in neuroplastic changes following focal brain ischemia in rats.

2009

The pathogenesis of ischemic stroke is a complex sequence of events including inflammatory reaction, for which the microglia appears to be a major cellular contributor. However, whether post-ischemic activation of microglial cells has beneficial or detrimental effects remains to be elucidated, in particular on long term brain plasticity events. The objective of our study was to determine, through modulation of post-stroke inflammatory response, to what extent microglial cells are involved in some specific events of neuronal plasticity, neurite outgrowth and synaptogenesis. Since microglia is a source of neurotrophic factors, the identification of the brain-derived neurophic factor (BDNF) as…

Brain InfarctionMaleTime FactorsNeuriteSciencePoly (ADP-Ribose) Polymerase-1SynaptophysinSynaptogenesisCell CountEnzyme-Linked Immunosorbent AssayNerve Tissue ProteinsBrain damageBiologyBrain IschemiaProinflammatory cytokineBrain ischemiaGAP-43 ProteinNeurotrophic factorsNeuroscience/Neuronal Signaling MechanismsmedicineAnimalsRats WistarCD11b AntigenNeuronal PlasticityMultidisciplinaryMicrogliaNeuroscience/Neuronal and Glial Cell BiologyBrain-Derived Neurotrophic FactorQRNeurological Disorders/Cerebrovascular DiseaseAntigens NuclearMacrophage Activationmedicine.diseaseImmunohistochemistryNeuroregenerationRatsEnzyme ActivationProtein Transportmedicine.anatomical_structureBenzamidesImmunologyMedicineMicrogliaPoly(ADP-ribose) Polymerasesmedicine.symptomNeuroscienceResearch ArticleNeurosciencePLoS ONE
researchProduct

2015

The recombinant form of tissue plasminogen activator (rt-PA) is the only curative treatment for ischemic stroke. Recently, t-PA has been linked to the metabolism of brain-derived neurotrophic factor (BDNF), a major neurotrophin involved in post-stroke neuroplasticity. Thus, the objective of our study was to investigate the impact of rt-PA treatment on post-stroke circulating BDNF levels in humans and in animals. Serum BDNF levels and t-PA/plasmin activity were measured at hospital admission and at up to 90 days in stroke patients receiving (n = 24) or not (n = 14) rt-PA perfusion. We investigated the relationships between serum BDNF with concurrent t-PA/plasmin activity, neurological outcom…

Brain-derived neurotrophic factor0303 health sciencesmedicine.medical_specialtyPathologyMultidisciplinaryPlasminbusiness.industrymedicine.diseaseTissue plasminogen activator3. Good healthBrain ischemia03 medical and health sciences0302 clinical medicineEndocrinologyBlood pressurenervous systemInternal medicinemedicineEndothelial dysfunctionbusinessStroke030217 neurology & neurosurgeryFibrinolytic agent030304 developmental biologymedicine.drugPLOS ONE
researchProduct

Stably BDNF-GFP expressing embryonic stem cells exhibit a BDNF release-dependent enhancement of neuronal differentiation

2013

Brain-derived neurotrophic factor (BDNF) is known to be a crucial regulator of neuronal survival and synaptic plasticity in the mammalian brain. Furthermore, BDNF positively influences differentiation of embryonic neural precursors as well as of neural stem cells from adult neurogenic niches. To study the impact of cell-released BDNF on neural differentiation of embryonic stem cells (ESCs), which represent an attractive source for cell transplantation studies, we have generated BDNF-GFP overexpressing mouse ESC clones by knock-in technology. After neural differentiation in vitro, we observed that BDNF-GFP overexpressing ESC clones gave rise to an increased number of neurons as compared to c…

Brain-derived neurotrophic factorCell BiologyAnatomyBiologyEmbryonic stem cellNeural stem cellCell biologyGreen fluorescent proteinTransplantationnervous systemNeurotrophic factorsembryonic structuresSynaptic plasticityGABAergicJournal of Cell Science
researchProduct

Exercise, Neuroplasticity, and Growth Factors in Adolescence

2015

Brain-derived neurotrophic factorInsulin-like growth factorNerve growth factorbusiness.industryNeurotrophic factorsmedicine.medical_treatmentNeuroplasticityVitamin D and neurologyMedicineCognitionbusinessNeuroscienceNeuropsychiatric disease
researchProduct

The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway

2015

The CB1 cannabinoid receptor, the main molecular target of endocannabinoids and cannabis active components, is the most abundant G protein-coupled receptor in the mammalian brain. In particular, the CB1 receptor is highly expressed in the basal ganglia, mostly on terminals of medium-sized spiny neurons, where it plays a key neuromodulatory function. The CB1 receptor also confers neuroprotection in various experimental models of striatal damage. However, the assessment of the physiological relevance and therapeutic potential of the CB1 receptor in basal ganglia-related diseases is hampered, at least in part, by the lack of knowledge of the precise mechanism of CB1 receptor neuroprotective ac…

Brain-derived neurotrophic factormedicine.medical_specialtyCannabinoid receptormusculoskeletal neural and ocular physiologymedicine.medical_treatmentCell BiologyBiologyEndocannabinoid systemδ-opioid receptorEndocrinologynervous systemInternal medicinemedicinelipids (amino acids peptides and proteins)CannabinoidSignal transductionReceptorMolecular BiologyProtein kinase BNeuroscienceCell Death & Differentiation
researchProduct